0
2021
Enteral Collagen Peptide Protein Market

Enteral Collagen Peptide Protein Market

by Form (Liquid & Powder), Age Group (Adults (above 18) & Pediatrics (below 18), and End User (Hospital & Clinics, Nursing Home, and Homecare): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A13675
Pages: 199
Tables: 114
Charts: 26
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030. Collagen peptide protein is a protein derived from animal collagen. Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients who are unable to consume sufficient nutrients orally, but whose gastrointestinal function is in a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or has underwent surgery that may interfere with the normal eating process. In this process, collagen peptides protein is administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.

Rise in the prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in applications of collagen peptide protein in the healthcare sector are the major factors driving the growth of the global enteral collagen peptide protein market. Furthermore, increase in geriatric population along with favorable government initiates to promote healthy diet among population are expected to provide lucrative opportunities for existing players and new entrants. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide new avenues for the expansion of the global market during the forecast period.

Enteral-Collagen-Peptide-Protein-Market-2021-2030

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on enteral collagen peptide protein market, owing to decline in meat consumption, especially marine and bovine products, across the globe. This factor has directly impacted the production of collagen peptides, as fish and beef wastes are major raw materials for collagen products. In addition, business collaborations and partnership opportunities for enteral collagen peptide protein are negatively affected by COVID-19 outbreak, which led to decline in the enteral collagen peptide protein products production. Thus, the enteral collagen peptide protein market has been negatively impacted due to the current global health crisis

Enteral Collagen Peptide Protein Market Segmentation  

The global enteral collagen peptide protein market is segmented into form, age group, end user, and region. On the basis of form, the enteral collagen peptide protein market is bifurcated into powder and liquid. By age group, it is classified into adults (above 18) and pediatrics (below 18). Depending on end user, it is fragmented into hospitals & clinics, homecare, and nursing home. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Segment review 

On the basis of form, the liquid segment is the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in the demand and consumption of enteral supplements that come in the form of liquid, due to increase in availability of liquid enteral collagen peptide protein products and rise in health concerns among consumers.

Enteral Collagen Peptide Protein Market
By Form

Your browser does not support the canvas element.

Liquid segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of age group, the adult (above 18 years) segment was the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to higher number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. Furthermore, increase in geriatric population that requires enteral collagen peptide protein and has difficulty in swallowing is expected to contribute toward the market growth.

Enteral Collagen Peptide Protein Market
By Age Group

Your browser does not support the canvas element.

Age Group Segment hold the dominant position and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By end user, the homecare segment is the major shareholder in the enteral collagen protein peptide market, owing to increase in number of patients adopting enteral collagen peptide protein products administration at home and increase in demand for home care enteral collagen peptide protein treatment. 

Enteral Collagen Peptide Protein Market
By End User

Your browser does not support the canvas element.

Home Care Segment hold the dominant position and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific enteral collagen peptide protein market  

Asia-Pacific presents lucrative opportunities for key players operating in the enteral collagen peptide protein market, owing to increase in geriatric population, R&D investments in developments of collagen peptide protein products for various chronic diseases, supportive government initiatives directed toward the reduction of the malnutrition deficiency, and significant surge in demand for advanced healthcare facilities.

Enteral Collagen Peptide Protein Market
By Country

2030
Europe 
North America
Asia-Pacific
LAMEA

Asia Pacific exhibit the highest CAGR of 9.2 % during 2021-2030

Get more information on this report : Request Sample Pages

Moreover, rise in number of people suffering from arthritis disease and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share are expected to drive growth of the enteral collagen peptide protein market in the region.

The key players profiled in this report include Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medline Industries, Inc, Global Health Products, Inc., OP2 labs, LLC, fresenius Kabi AG, Gelita AG, and Weishardt Holding SA.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the enteral collagen peptide protein market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers enteral collagen peptide protein market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global enteral collagen peptide protein market growth.

Key Market Segments

By Form

  • Powder
  • Liquid

By Age Group

  • Adults (Above 18)
  • Pediatrics (Below 18)

By End User

  • Hospitals & Clinics
  • Homecare
  • Nursing Home

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Enteral Collagen Peptide Protein Market Report Highlights

Aspects Details
By FORM
  • Powder
  • Liquid
By AGE GROUP
  • Adults (above18)
  • Pediatric (below 18 years)
By END USER
  • Hospitals & clinics
  • Homecare
  • Nursing home
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players GLOBAL HEALTH PRODUCTS, INC., .FRESENIUS KABI AG, GELITA AG, MEDTRITION INC., OP2 LABS LLC, MEDLINE INDUSTRIES, INC., ABBOTT LABORATORIES, WEISHARDT HOLDING SA, DANONE S.A. (NUTRICIA), DERMARITE INDUSTRIES LLC
 

Loading Table Of Content...


 
 

Enteral collagen peptide protein is recommended for patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. In enteral feeding system, nutrition or medications are directly administered in the stomach or intestine.

Factors such as rise in sale of enteral collagen peptide protein products, consumer focus on protein-rich diets, and rise in use of collagen peptide protein in the healthcare industry due to their high protein content drive the growth of market. In addition, increase in investment in R&D activities to develop innovative products and rise in number of malnutrition cases drives the growth of the market. Moreover, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth during the forecast period.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
Published Date :
Sep 2021
Author(s) : Sushant T , Onkar S
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Enteral Collagen Peptide Protein Market is $ 25,811 Thousand in 2020

A. The forecast period in the report is from 2021 to 2030

A. The market value of Enteral Collagen Peptide Protein in 2020 was 14,586 Thousand

A. Yes, Enteral Collagen Peptide Protein Market companies are profiled in the report

A. The top companies that hold the market share in Enteral Collagen Peptide Protein Market are are Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medlin Industries

A. No, there is no value chain analysis provided in the Enteral Collagen Peptide Protein Market report

A. The key trends in the Enteral Collagen Peptide Protein Market are increase in number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis and increase in demand for home care enteral collagen peptide protein treatment

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
Related Tags

Purchase Full Report of
Enteral Collagen Peptide Protein Market

Start reading instantly.
This Report and over 71,323+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2022 - Sep 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2022 - Sep 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2022 - Sep 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2022 - Sep 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2022 - Sep 2023)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers